The 'cell of origin' of the second most common lung cancer and the way that it becomes dominant in the lung have been discovered, in a new study in mice and humans from researchers at UCL, the ...

A memo from the head of the National Institute for Occupational Safety and Health said the reinstatements were only temporary ...

Dr. Bryant Lin explains how his stage IV lung cancer diagnosis didn’t defeat him but instead inspired a revolutionary class.

An FDA-designated orphan drug that can target a key vulnerability in lung cancer shows promise in improving the efficacy of ...

Most new emphysema is propagated in high mechanically affected lung regions rather than in lung areas with small airways disease.

People with diseases caused by rare mutations have fewer options and poorer prospects than other patients despite rapid ...

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

She visited Fann hospital in Dakar, where neurologist Dr. Pedro Rodriguez Cruz measured her lung capacity. He suspects ...